China Resources Pharmaceutical Plans Indirect Acquisition of About 23.50% Stake in Lier Chemical

Corporate Action
โดย 南方财经网·Read original
Summary · why it matters

China Resources Pharmaceutical has issued an inside information announcement stating that its indirect non-wholly-owned subsidiary, China Resources Double-Crane Pharmaceutical, intends to acquire approximately 23.50% of the shares in Lier Chemical. The transaction involves 188.1027 million shares of Lier Chemical, initiated by Sichuan Jiuyuan Investment Holding Group and Sichuan Huacai Technology through a public solicitation transfer. As of the announcement date, China Resources Double-Crane does not hold any shares in Lier Chemical. The potential acquisition is still subject to the signing of a formal transaction agreement and the satisfaction of relevant conditions, and there are uncertainties.

Impact on stocks 3

Biotech & Genomic Medicine▲ · 1 stocks
Others▲ · 2 stocks
Lier Chemical Co Ltd
002258
▲ PositiveCapitalrelevance

Lier Chemical is the target of a 23.50% stake acquisition by China Resources Double-Crane, likely boosting its valuation.

Off-coverage companies 2

Sichuan Jiuyuan Investment Holding Group Co LtdPrivate± Mixed
relevance

四川化材科技有限公司Private± Mixed
relevance

© 2026 MarketDXNews